Welcome Guest | Register / Login

Breast Cancer Market Research Reports

Sort By
Title Published Price
Global Breast Cancer Partnering 2010 to 2016
By Current Partnering
"Delivery of this report will take 1-3 days after purchase." Summary Provides comprehensive understanding and unprecedented access t- breast cancer partnering deals and agreements entered int- by the worlds leadi...
Jul 2016 $ 1495
Breast Cancer Treatment Drug Industry Forecasts - China Focus
By AMID
This study focuses on China's Breast Cancer Treatment Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chin...
Mar 2016 $ 1000
Hormone Refractory Breast Cancer-Pipeline Insights, 2016
By Delve Insight
SUMMARY DelveInsight's, " Hormone Refractory Breast Cancer-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Hormone Refractory Breast Cancer. The DelveInsight'sRepor...
Jan 2016 $ 1250
Global Breast Cancer Market Report: 2015 Edition
By Koncept Analytics
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer ...
Aug 2015 $ 800
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide
By Renub Research
Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening glob...
Sep 2014 $ 1490
Global Breast Cancer Market Report: 2014 Edition
By Koncept Analytics
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer ...
Aug 2014 $ 800
Disease and Therapy Review: Breast Cancer
By Timely Data resources
The Breast Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, and a detailed overv...
Jul 2013 $ 995
Hormone Refractory Breast Cancer – Pipeline Review, H2 2012
By Global Markets Direct
 "Hormone Refractory Breast Cancer – Pipeline Review, H2 2012SummaryGlobal Markets Direct’s, 'Hormone Refractory Breast Cancer - Pipeline Review, H2 2012', provides an overview of t...
Jul 2012 $ 500
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012
By GlobalData
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relati...
Jan 2012 $ 1000
Metastatic Breast Cancer – Pipeline Review, H1 2012
By Global Markets Direct
Metastatic Breast Cancer – Pipeline Review, H1 2012SummaryGlobal Markets Direct’s, 'Metastatic Breast Cancer - Pipeline Review, H1 2012', provides an overview of the Metastatic Breast Cancer therapeutic pipeli...
Jan 2012 $ 500
Breast Cancer – Pipeline Review, H1 2012
By Global Markets Direct
Breast Cancer – Pipeline Review, H1 2012SummaryGlobal Markets Direct’s, 'Breast Cancer - Pipeline Review, H1 2012', provides an overview of the Breast Cancer therapeutic pipeline. This report provides informat...
Jan 2012 $ 500
Metastatic Breast Cancer - Pipeline Review, Q3 2011
By Global Markets Direct
Report SummaryGlobal Markets Direct’s, 'Metastatic Breast Cancer - Pipeline Review, Q3 2011', provides an overview of the Metastatic Breast Cancer ther...
Jul 2011 $ 500
Breast Cancer - Pipeline Review, Q3 2011
By Global Markets Direct
Report SummaryGlobal Markets Direct’s, 'Breast Cancer - Pipeline Review, Q3 2011', provides an overview of the Breast Cancer therapeutic pipeline...
Jul 2011 $ 500
Breast Cancer Market Report: 2011 Edition
By Koncept Analytics
Breast cancer is one of the most common types of cancer after lung cancer and the second leading cause of death in women. Globally, more than one million women are diagnosed with breast cancer annually. Breast cancer is mainly found in wome...
Jun 2011 $ 800
FDA Withdraws Approval of Avastin in Breast Cancer
By GlobalData
Report SummaryGlobalData’s report, “FFDA Withdraws Approval of Avastin in Breast Cancer” provides key data, information on Breast Cancer Therapy Ma...
Jan 2011 $ 500
Metastatic Breast Cancer - Pipeline Review, Q1 2011
By Global Markets Direct
Metastatic Breast Cancer - Pipeline Review, Q1 2011SummaryGlobal Markets Direct’s, 'Metastatic Breast Cancer - Pipeline Review, Q1 2011', provides an overview of the Metastatic Breast Cancer therapeutic pipeline. This r...
Jan 2011 $ 500